Neuronetics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Neuronetics, Inc. (STIM) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-43.73-30.19-37.16-31.19-27.45-29.04-24.10
Depreciation & Amortization2.072.011.651.780.941.820.88
Stock Based Compensation5.607.328.757.874.400.000.00
Change in Working Capital-6.81-14.10-5.12-5.04-8.280.17-1.58
Change in Accounts Receivable-3.73-8.83-6.66-3.82-0.600.000.00
Change in Inventory3.15-1.10-2.59-3.44-0.950.000.00
Change in Accounts Payable-1.992.03-1.970.28-1.090.000.00
Change in Other Working Capital-4.250.630.800.92-5.080.000.00
Other Operating Activities11.860.630.806.471.99-3.421.07
Net Cash from Operating Activities-31.00-32.04-30.74-28.00-28.39-30.50-20.59
Investing Activities
Capital Expenditures-1.47-2.37-3.272.35-0.730.81-1.01
Acquisitions-2.550.000.000.000.000.000.00
Sales/Maturities of Investments1.001.0510.00-7.490.000.000.00
Other Investing Activities0.611.0510.00-7.490.000.000.00
Net Cash from Investing Activities-2.41-1.326.73-9.84-0.73-0.81-1.01
Financing Activities
Debt Repayment-5.15-1.20-0.090.00-39.680.000.00
Common Stock Issued2.520.000.3080.970.690.00100.00
Other Financing Activities-4.19-1.10-0.09-0.40-0.820.00-3.46
Net Cash from Financing Activities-6.8122.700.2183.012.372.4297.04
Summary
Net Change in Cash-40.22-10.66-23.8045.18-26.75-28.8875.44
Cash at Beginning of Period59.6870.3494.1448.9675.71104.5829.15
Cash at End of Period19.4659.6870.3494.1448.9675.71104.58
Free Cash Flow-32.46-34.41-34.01-30.35-29.12-31.31-21.60
Supplemental Disclosures
Interest Paid6.514.793.543.303.892.952.79